JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 126 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $149 | +67.4% | 80,336 | 0.0% | 0.00% | – |
Q4 2022 | $89 | -99.9% | 80,336 | +104.2% | 0.00% | – |
Q3 2022 | $93,000 | +57.6% | 39,336 | +100.5% | 0.00% | – |
Q2 2022 | $59,000 | -86.5% | 19,618 | -69.5% | 0.00% | – |
Q1 2022 | $437,000 | +414.1% | 64,309 | +530.9% | 0.00% | – |
Q4 2021 | $85,000 | -94.3% | 10,194 | -94.9% | 0.00% | – |
Q3 2021 | $1,497,000 | +18.4% | 201,494 | +8.4% | 0.00% | – |
Q2 2021 | $1,264,000 | -12.5% | 185,858 | +32.2% | 0.00% | – |
Q1 2021 | $1,444,000 | +96.5% | 140,626 | +33.9% | 0.00% | – |
Q4 2020 | $735,000 | – | 104,996 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |